illusio Research by SuperAGI

Overview

ILLUSIO Inc. is a privately held software development company specializing in augmented reality (AR) visualization systems tailored for cosmetic surgery. Established in 2015, the company is headquartered in San Clemente, California. With a focus on transforming aesthetic consultations through innovatively designed AR tools, ILLUSIO aims to bridge the communication gap between patients and surgeons by providing visual simulations of surgical outcomes.

Key Details:

Website: [illusioimaging.com](http://www.illusioimaging.com)

Headquarters: 1211 Puerta del Sol, Suite #220, San Clemente, California 92673, US

Industry: Software Development

Company Size: 2-10 employees

Founder & CEO: Ethan S. Winner

Core Technology

ILLUSIO™ offers a Virtual Mirror platform that integrates a 3D virtual image of a patient’s body with a live image, allowing real-time visualization of the potential results of breast augmentation and other aesthetic procedures. The technology enables surgeons to manipulate virtual representations of the patient’s breasts during consultations to provide a clear and personalized view of the potential surgical outcomes.

Key technological features include:

3D scan of the patient’s body.

Real-time rendering and manipulation of breast images.

Utilization of data analysis and AI for predictive modeling.

Achievements and Recognition

ILLUSIO has been acknowledged for its groundbreaking contributions to the field of medical imaging:

Internet Marketing Association's 2023 Impact Awards winner for their innovative use of AI and AR technology in the medical sector.

Funding and Financial Information

ILLUSIO has completed two funding rounds, with the latest being an equity crowdfunding round in December 2019, raising US $234.2K. Their primary investor is Equifund.

Strategic Vision

ILLUSIO is focused on expanding its AR visualization platform to other aesthetic procedures such as liposuction and abdominoplasty. The company’s strategy includes leveraging historical data and AI to enhance their predictive modeling capabilities, thereby improving patient engagement and decision-making during consultations.

Specialties:

Medical Imaging

Augmented Reality

Cosmetic Surgery Imaging

Computer Software

Meta and File Compression

Leadership

Ethan S. Winner

Role: Founder & CEO

Background: Extensive experience in global communications and corporate operations. Leads the strategic direction and day-to-day management of ILLUSIO.

LinkedIn: [Ethan S. Winner](https://www.linkedin.com/in/ethanwinner1)

Competitor Profiling for ILLUSIO

Overview of Competitors

Key Competitors:

1. Teladoc Health, Inc.

Industry: Multinational telemedicine and virtual healthcare.

Services: Telehealth services including acute, chronic, behavioral, and specialty care.

Headquarters: Purchase, NY.

Key Financials: Reports an annual revenue of $43.5M.

Notable: The only virtual-first, whole-person care company connecting patients through advanced technology and providing comprehensive virtual care solutions.

2. Grand Rounds Health (now Included Health)

Industry: Integrated virtual care and navigation.

Services: Virtual and in-person care encompassing acute, chronic, behavioral, and primary care.

Headquarters: San Francisco, CA.

Company Size: 501-1,000 employees.

Notable: Raised $281M in funding, offering expert medical opinions, clinical navigation, and employee benefits services.

3. Accolade, Inc.

Industry: Health, wellness, and fitness.

Services: Personalized healthcare delivery, navigation, and advocacy.

Headquarters: Plymouth Meeting, PA.

Key Financials: Subsidiary of Wendel SE, promotes technology-enabled solutions for healthcare understanding and navigation.

Notable: Focuses on human connection over automation, utilizing data-driven and value-based approaches.

4. Transcarent

Industry: Consumer-directed health and care platform.

Services: Comprehensive care and navigation for employees of self-insured employers.

Headquarters: California.

Funding: Raised $450M over 2 funding rounds.

Notable: Leverages generative AI and top clinical expertise to provide high-quality, affordable healthcare.

Detailed Insights

Teladoc Health, Inc.

Teladoc Health stands out as a global leader in virtual care, focusing on comprehensive telehealth services. Their emphasis on seamless tech integration for patient care ensures a trusted, holistic approach which might provide competitive pressure in the tech-driven healthcare domain. Their extensive service portfolio includes talk therapy, medication support, chronic condition management, and 24/7 acute care access, making them a significant player in virtual health solutions.

Grand Rounds Health (Included Health)

Grand Rounds Health, recently rebranded as Included Health, integrates virtual care with expert clinical navigation, providing sophisticated healthcare solutions to users. Their prominent funding trajectory ($281M) signifies robust financial health and potential growth prospects. The company’s dual focus on acute and chronic condition management, alongside behavioral and physical health services, positions it as a comprehensive care provider, potentially rivaling Illusio’s healthcare offerings.

Accolade, Inc.

Accolade Inc.'s unique proposition lies in its personalized, human-centric healthcare delivery. Unlike competitors relying heavily on AI, Accolade integrates intelligent technology to forge personal connections, ensuring a superior healthcare experience. Their services, aimed at guiding users through the complexities of the healthcare system, stand out in improving user experience and retention. Their strong belief in a personalized approach to healthcare echoes a commitment likely valued by end-users.

Transcarent

Transcarent’s dedication to transforming the healthcare experience through simplified access and transparent information positions it uniquely. The company’s strategic integration of AI and top clinical knowledge addresses both the technological and human aspects of healthcare, aligning well with market demand for efficient, accessible, and patient-centric services. Their robust development, highlighted by significant funding, underscores their relevance and potential threat in the competitive landscape.

Key Takeaways:

ILLUSIO must keenly observe Teladoc’s integrated tech solutions and extensive telehealth service range to adapt and enhance its offerings.

Monitoring Included Health’s funding strategies and comprehensive service delivery could provide strategic insights into sustaining growth and expanding service lines.

Accolade’s focus on human-centric services highlights the importance of balancing technology with personal interaction in healthcare delivery.

Transcarent’s innovative use of AI and comprehensive care approach reinforces the need for continuous innovation in service models to remain competitive.

Strategic Implications:

Innovation and Technology: ILLUSIO should prioritize enhancing its tech capabilities and consider incorporating AI to streamline operations and improve patient care quality.

Comprehensive Service Providing: Expanding into broader healthcare services, including mental health and chronic care, may offer potential growth avenues.